Drug Shortage Report for ROBAXISAL C 1/2
| Report ID | 136006 |
| Drug Identification Number | 01934791 |
| Brand name | ROBAXISAL C 1/2 |
| Common or Proper name | NA |
| Company Name | GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | CODEINE PHOSPHATE METHOCARBAMOL ACETYLSALICYLIC ACID |
| Strength(s) | 32.4MG 400MG 325MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 250 |
| ATC code | N02AA |
| ATC description | OPIOIDS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2021-07-05 |
| Actual start date | |
| Estimated end date | 2022-10-10 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2022-07-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 55 STANDISH COURT MISSISSAUGA, ONTARIO CANADA L5R 4B2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-07-06 | French | Compare |
| v7 | 2022-07-06 | English | Compare |
| v6 | 2022-02-02 | French | Compare |
| v5 | 2022-02-02 | French | Compare |
| v4 | 2022-02-02 | English | Compare |
| v3 | 2021-07-06 | English | Compare |
| v2 | 2021-03-19 | French | Compare |
| v1 | 2021-03-19 | English | Compare |
Showing 1 to 8 of 8